Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice

[1]  Zhifei Wang,et al.  Human Cytomegalovirus-IE2 Affects Embryonic Liver Development and Survival in Transgenic Mouse , 2022, Cellular and molecular gastroenterology and hepatology.

[2]  Z. Tian,et al.  Chrysin enhances antitumour immunity response through the IL‐12‐STAT4 signal pathway in the B16F10 melanoma mouse model , 2022, Scandinavian journal of immunology.

[3]  Yung-Fu Chang,et al.  Toxic effects of copper on the jejunum and colon of pigs: mechanisms related to gut barrier dysfunction and inflammation influenced by the gut microbiota. , 2021, Food & function.

[4]  Jared L. Johnson,et al.  Dietary fructose improves intestinal cell survival and nutrient absorption , 2021, Nature.

[5]  M. Jin,et al.  Intestinal Microbiota Mediates High-Fructose and High-Fat Diets to Induce Chronic Intestinal Inflammation , 2021, Frontiers in Cellular and Infection Microbiology.

[6]  Changtao Jiang,et al.  The role of the gut microbiome and its metabolites in metabolic diseases , 2020, Protein & Cell.

[7]  Shihong Chen,et al.  Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota. , 2020, Diabetes research and clinical practice.

[8]  R. Valdés-Mas,et al.  Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice , 2019, Nature Medicine.

[9]  M. McCarthy,et al.  Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases , 2019, Nature Genetics.

[10]  E. Dirinck,et al.  The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity , 2019, Front. Immunol..

[11]  A. Gasbarrini,et al.  Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease , 2019, World journal of gastroenterology.

[12]  J. Bluestone,et al.  Revisiting IL-2: Biology and therapeutic prospects , 2018, Science Immunology.

[13]  M. Do,et al.  High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change , 2018, Nutrients.

[14]  K. Nadeau,et al.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. , 2018, Journal of hepatology.

[15]  C. Kahn,et al.  Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling , 2017, The Journal of clinical investigation.

[16]  M. Serlie,et al.  Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease , 2017, Nutrients.

[17]  A. Roda,et al.  Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review , 2017, Nutrients.

[18]  J. de Bandt,et al.  Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism , 2017, Nutrients.

[19]  X. Chen,et al.  Tlr4-mutant mice are resistant to acute alcohol-induced sterol-regulatory element binding protein activation and hepatic lipid accumulation , 2016, Scientific Reports.

[20]  A. Bulboacă,et al.  Protective effect of curcumin in fructose-induced metabolic syndrome and in streptozotocin-induced diabetes in rats , 2016, Iranian journal of basic medical sciences.

[21]  P. Jorens,et al.  The role of Th17 and Treg responses in the pathogenesis of RSV infection , 2015, Pediatric Research.

[22]  Margaret J. Morris,et al.  Changes in Gut Microbiota in Rats Fed a High Fat Diet Correlate with Obesity-Associated Metabolic Parameters , 2015, PloS one.

[23]  E. Elinav,et al.  The cross talk between microbiota and the immune system: metabolites take center stage. , 2014, Current opinion in immunology.

[24]  M. Vinciguerra,et al.  Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease , 2014, Aging.

[25]  D. Sabatini,et al.  Dietary and metabolic control of stem cell function in physiology and cancer. , 2014, Cell stem cell.

[26]  Zhuye Jie,et al.  Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance , 2013, PloS one.

[27]  M. Lanaspa,et al.  Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection? , 2013, Journal of equine veterinary science.

[28]  J. Segre,et al.  The human microbiome: our second genome. , 2012, Annual review of genomics and human genetics.

[29]  G. Nardone,et al.  Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[30]  R. Alfenas,et al.  Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia , 2012, British Journal of Nutrition.

[31]  S. Bischoff,et al.  Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. , 2011, The Journal of nutritional biochemistry.

[32]  V. Samuel.  Fructose induced lipogenesis: from sugar to fat to insulin resistance , 2011, Trends in Endocrinology & Metabolism.

[33]  A. Cherrington,et al.  Chronic consumption of a high-fat/high-fructose diet renders the liver incapable of net hepatic glucose uptake. , 2010, American journal of physiology. Endocrinology and metabolism.

[34]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[35]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[36]  S. Bischoff,et al.  Toll‐like receptor 4 is involved in the development of fructose‐induced hepatic steatosis in mice , 2009, Hepatology.

[37]  I. Bergheim,et al.  Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. , 2009, The Journal of nutritional biochemistry.

[38]  R. Ley,et al.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes , 2008, Nature.

[39]  W. Paul,et al.  CD4 T cells: fates, functions, and faults. , 2008, Blood.

[40]  P. Libby,et al.  Interferon- (cid:1) , a Th1 Cytokine, Regulates Fat Inflammation A Role for Adaptive Immunity in Obesity , 2022 .

[41]  S. Bischoff,et al.  Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. , 2008, The Journal of nutrition.

[42]  C. McClain,et al.  Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. , 2008, Journal of hepatology.

[43]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[44]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[45]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. Havel.  Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. , 2005, Nutrition reviews.

[47]  Khosrow Adeli,et al.  Fructose, insulin resistance, and metabolic dyslipidemia , 2005, Nutrition & metabolism.

[48]  W. Seeger,et al.  Human Endothelial Cell Activation and Mediator Release in Response to Listeria monocytogenesVirulence Factors , 2001, Infection and Immunity.

[49]  M. Wilson,et al.  Regulation of intestinal blood flow. , 2000, The Journal of surgical research.

[50]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[51]  C. Mackay,et al.  Diet, gut microbiota and immune responses , 2010, Nature Immunology.